Systemic therapy represents the standard of care treatment for patients with advanced hepatocellular carcinoma (HCC). Given the increased risk of death from cirrhosis-related complications in patients ...

The risk of dying from the most common form of primary liver cancer is about 30% higher for patients with low household ...

SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company pioneering TCR T cell therapy for infectious diseases and associated cancers, today announced late-breaking clinical data from ...

The risk of dying from the most common form of primary liver cancer is approximately 30% higher for patients with low ...

Researchers have found in a new cohort study that the use of statins in patients with chronic liver disease was associated ...

In the study population of more than 30,000 people without known liver disease, the proportion of persons with a liver ...

Gastrointestinal cancers often develop silently but knowing risk factors and warning signs can lead to earlier detection and ...